Baxter Oncology English
Products
Health Care Professionals
Patients
Quality Management
Contract Manufacturing
Manufacturing
Organization Contact Us Sitemap Baxter Oncology Homepage Baxter Homepage
 

Our Oncology business has been established worldwide with standard therapy products for cancer, such as ENDOXAN (cyclophosphamide), HOLOXAN (ifosfamide), and UROMITEXAN (mesna), for over 40 years. This product range has been steadily expanded to include MILTEX (miltefosine), ONKOTRONE (mitoxantrone), BLEOMYCIN (Bleomycin) and others, some only available regionally.

The long-term objective is to help improve the treatment of cancer patients worldwide through the development, production, marketing, and sale of new, improved products in close cooperation with physicians, pharmacists, other care personnel, renowned scientists, organizations and associations, and with committed partner companies.
EHA, June 14th - 17th, Amsterdam, Please visit the Baxter booth

CSCO (15th Annual Meeting of Chinese Society of Clinical Oncology), Sept. 19th - 23rd, Beijing, Please visit the Baxter booth

ECOP (1st European Conference on Oncology Pharmacy), Sept. 27th - 29th, Budapest, Please visit the Baxter booth

ESMO, Sept. 28th - Oct. 2nd, Vienna, Please visit the Baxter booth

SIOP, Oct. 5th - 8th, London, Please visit the Baxter booth

DGHO, Oct. 19th - 23rd, Stuttgart, Please visit the Baxter booth

JCO Reprint of CORAL Study available

16th Edition of Selected Schedules available

 

Copyright © 2012 Baxter Oncology GmbH. All rights reserved.
Copyright and Legal Disclaimer